Categories: News

Navitar Focus on Start-Ups Program Provides Dedicated Engineering and Manufacturing Resources to Help Start-Up Companies Launch New Products

ROCHESTER, N.Y., Nov. 16, 2021 /PRNewswire/ — Navitar, Inc. a provider of microscopy imaging solutions for highly complex medical instruments and products within the life science, biotech and industrial imaging system markets, is pleased to announce the launch of their Focus on Start-Ups program aimed to help new start-up companies move their innovative product concepts to reality, setting new standards for performance and beating the competition to market.

The Navitar Focus on Start-Ups program aims to help companies move their innovative product concepts to reality.

The newly launched Navitar Focus on Start-Ups program provides support to medical, life science, and biotech companies looking to develop new imaging products and grow their businesses. Jeremy Goldstein, co-CEO and owner of Navitar says, “Start-Ups want to develop and commercialize cutting-edge instruments, devices, and equipment at breakneck speeds. We have the engineering experience, optical components, custom sensor technology, and vertically integrated manufacturing capabilities to help these companies move their ideas from proof of concept to design and into production.”

Members of the program will have access to a dedicated design team of optical, mechanical, electrical and application engineers, quality assurance specialists, and experts in obtaining and protecting intellectual property. Navitar offers expert optical modeling of sensor, lens, objective and tube lens combinations, unique imaging system configurations, custom camera firmware, and lens and sensor active alignment capabilities.

The newly launched program will help start-up companies reduce product development risks, decrease costs, and shorten time to market by ensuring all ISO 13485, FDA, IEC, FCC, and CE requirements are followed.  Start-up companies will receive a well thought-out opto-mechanical design optimized for imaging performance and competitive success.

To join Navitar’s Focus on Start-Ups program visit navitar.com/startups/ or call 585-359-4000.

###

ABOUT NAVITAR
Navitar has been designing and manufacturing thousands of unique lens systems and integrated camera and lens solutions for over 60 years.  Our leading design team has cataloged thousands of base designs ranging from microscope objectives, custom cameras, and complete custom microscopy imaging systems.  Navitar’s extensive background IP helps shorten design times and ensures diffraction limited performance.  Navitar works with large established OEM life science and industrial equipment makers along with researchers and new start-up companies.

View original content to download multimedia:https://www.prnewswire.com/news-releases/navitar-focus-on-start-ups-program-provides-dedicated-engineering-and-manufacturing-resources-to-help-start-up-companies-launch-new-products-301423435.html

SOURCE Navitar, Inc.

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

1 day ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

1 day ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

1 day ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

1 day ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

1 day ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

1 day ago